Sign In
Buy AQSZF
$0.0011
+0 (+0%)
At Close: Jun 22, 2026
Aequus Pharmaceuticals Earnings Calls
Mar 31, 2026
(Today)
| Release date | Jun 23, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 3.13% |
Dec 31, 2025
| Release date | May 19, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Sep 30, 2025
| Release date | Dec 01, 2025 |
| EPS estimate | - |
| EPS actual | $0.0020 |
| Revenue estimate | - |
| Revenue actual | 180.503K |
Jun 30, 2025
| Release date | Aug 27, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0009 |
| Revenue estimate | - |
| Revenue actual | 160.169K |
Last 4 Quarters for Aequus Pharmaceuticals
Below you can see how AQSZF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Jun 30, 2025
| Release date | Aug 27, 2025 |
| Price on release | $0.0034 |
| EPS estimate | - |
| EPS actual | -$0.0009 |
| Date | Price |
|---|---|
| Aug 21, 2025 | $0.0048 |
| Aug 22, 2025 | $0.0035 |
| Aug 25, 2025 | $0.0035 |
| Aug 26, 2025 | $0.0034 |
| Aug 27, 2025 | $0.0034 |
| Aug 28, 2025 | $0.0034 |
| Aug 29, 2025 | $0.0034 |
| Sep 01, 2025 | $0.0034 |
| Sep 02, 2025 | $0.0034 |
| 4 days before | -29.17% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -29.17% |
Sep 30, 2025
| Release date | Dec 01, 2025 |
| Price on release | $0.0012 |
| EPS estimate | - |
| EPS actual | $0.0020 |
| Date | Price |
|---|---|
| Nov 25, 2025 | $0.0012 |
| Nov 26, 2025 | $0.0012 |
| Nov 27, 2025 | $0.0012 |
| Nov 28, 2025 | $0.0012 |
| Dec 01, 2025 | $0.0012 |
| Dec 02, 2025 | $0.0012 |
| Dec 03, 2025 | $0.0012 |
| Dec 04, 2025 | $0.0012 |
| Dec 05, 2025 | $0.0012 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Dec 31, 2025
| Release date | May 19, 2026 |
| Price on release | $0.0011 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| May 13, 2026 | $0.0024 |
| May 14, 2026 | $0.0024 |
| May 15, 2026 | $0.0024 |
| May 18, 2026 | $0.0011 |
| May 19, 2026 | $0.0011 |
| May 20, 2026 | $0.0011 |
| May 21, 2026 | $0.0011 |
| May 22, 2026 | $0.0011 |
| May 26, 2026 | $0.0011 |
| 4 days before | -54.17% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -54.17% |
Mar 31, 2026
(Today)
| Release date | Jun 23, 2026 |
| Price on release | - |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 15, 2026 | $0.0026 |
| Jun 16, 2026 | $0.0019 |
| Jun 17, 2026 | $0.0019 |
| Jun 18, 2026 | $0.0011 |
| Jun 22, 2026 | $0.0011 |
Aequus Pharmaceuticals Earnings History
Earnings Calendar
FAQ
When is the earnings report for AQSZF?
Aequus Pharmaceuticals Inc. (AQSZF) has scheduled its earnings report for Jun 23, 2026 after the markets close.
What is the AQSZF price-to-earnings (P/E) ratio?
AQSZF P/E ratio as of Jun 22, 2026 (TTM) is -1.01.
What is the AQSZF EPS forecast?
The forecasted EPS (Earnings Per Share) for Aequus Pharmaceuticals Inc. (AQSZF) for the first fiscal quarter 2026 is $.
What are Aequus Pharmaceuticals Inc.'s retained earnings?
On its balance sheet, Aequus Pharmaceuticals Inc. reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
